Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
Holding ANNX?
Track your performance easily

Annexon Biosciences (ANNX) Ownership - Who Owns Annexon Biosciences?

843 Followers

Annexon Biosciences (ANNX) Ownership Overview

13.78%15.10%0.36%11.61%59.16%
13.78% Insiders
0.36% Other Institutional Investors
11.61% ETFs
59.16% Public Companies and Individual Investors
The ownership structure of Annexon Biosciences (ANNX) stock is a mix of institutional, retail, and individual investors. Approximately 27.07% of the company’s stock is owned by Institutional Investors, 13.78% is owned by Insiders, and 59.16% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Jul 17, 2024
Ted Yednock
Evp & Chief Innovation Officer
xxxxxxxxxxxxx
$6658
Feb 21, 2024
Ted Yednock
Evp & Chief Innovation Officer
xxxxxxxxxxxxx
$14348
Feb 21, 2024
Jennifer Lew
Evp & Cfo
xxxxxxxxxxxxx
$14339
Feb 21, 2024
Michael Overdorf
Evp & Chief Business Officer
xxxxxxxxxxxxx
$10691

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$27038
Jun 30, 2024
xxxxxxxxxxxxx
$107780
Jun 30, 2024
xxxxxxxxxxxxx
$14405730
Jun 30, 2024
xxxxxxxxxxxxx
$19951217

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
7,406,024Insider7.01%55,841,421
4,868,603Insider6.20%36,709,267
4,783,036Institution4.53%36,064,091
4,071,677Institution3.85%30,700,445
3,869,914Institution3.66%29,179,152
3,755,033Institution3.55%28,312,949
2,939,945Institution2.78%22,167,185
2,766,677Institution2.62%20,860,745
2,049,955Institution1.94%15,456,661
1,830,597Institution1.73%13,802,701

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
3,869,914Institution3.66%29,179,152
2,766,677Institution2.62%20,860,745
1,830,597Institution1.73%13,802,701
1,515,204Institution1.43%11,424,638
961,228Institution0.91%7,247,659
883,476Institution0.84%6,661,409
668,226Institution0.63%5,038,424
644,355Institution0.61%4,858,437
508,833Institution0.48%3,836,601
501,548Institution0.47%3,781,672

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,474,329Institution2.34%18,656,441
2,829,766Institution2.68%16,752,215
1,932,434Institution1.83%14,628,525
1,303,486Institution1.23%7,716,637
909,556Institution0.86%6,858,052
414,071Institution0.39%3,134,517
437,140Institution0.41%2,587,869
248,032Institution0.23%1,877,602
220,013Institution0.21%1,658,898
157,604Institution0.15%1,193,062

FAQ

Who Owns Annexon Biosciences (ANNX)?
According to the latest TipRanks data, approximately 0.36% of the company's stock is held by institutional investors, 13.78% is held by insiders, and 59.16% is held by retail investors.
    What percentage of Annexon Biosciences (ANNX) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.36% of Annexon Biosciences (ANNX) stock is held by institutional investors.
      What percentage of Annexon Biosciences (ANNX) stock is held by retail investors?
      According to the latest TipRanks data, approximately 59.16% of Annexon Biosciences (ANNX) stock is held by retail investors.
        Who owns the most shares of Annexon Biosciences (ANNX)?
        Muneer Satter owns the most shares of Annexon Biosciences (ANNX).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis